Cambridge Cancer Genomics

InactiveAI-native

CCG.ai empowers clinicians to make personalised treatment strategies…

What it does

CCG.ai exist to ensure that each patient has the right drug, at the right time, to beat their cancer. ‍ We build the software to enable data-driven precision oncology and systematically develop data-driven biomarkers indicative of treatment response. We believe that increasing amounts of clinical and genomic data have the potential to transform cancer treatment, and enable oncologists to make smarter decisions about which drug to use in which circumstance. We are expanding our team in Cambridge, UK, offering a fantastic opportunity for dedicated individuals who are comfortable in a high-work high-reward environment, and who are enthusiastic for a dynamic and varied role. We are looking for people who fit well into our team and company culture, and who like to overcome challenges and drive the business forward. In exchange, we offer a competitive salary with performance related bonuses and stock options, alongside excellent career development opportunities in a fast-growing start-up with a chance to truly impact how cancer is treated. To apply, please send your CV to info@ccg.ai

Next to it in Healthcare and bio · precision oncology genomics software

  • OaCP IE LTDSOSV SOSV IndieBio RebelBio 04

    Accelerating cancer diagnostics, precision medicine, and personal genomics

  • Dropprint GenomicsY Combinator W20

    The better way to run single cell genomics

  • IsablY Combinator W20

    Cancer tests based on whole genome and transcriptome data.

  • FidoCure®Y Combinator W18

    FidoCure® is the leader in Precision Medicine for Canine Oncology.

  • DropGenieSOSV SOSV IndieBio RebelBio 06

    Gene editing at the click of a button

  • EnzymeY Combinator S17

    Automating regulatory approval & compliance for life science companies

  • OncoboxY Combinator S17

    Finding the right cancer drug for each patient.

  • 54GeneY Combinator W19

    Precision medicine for Africans and the global population